DUQUESNE UNIV OF THE HOLY GHOST has a total of 21 patent applications. Its first patent ever was published in 1996. It filed its patents most often in United States, Australia and Japan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are NPS PHARMA INC, ABBOTT GMBH & AMP CO KG and KALVINS IVARS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 3 | |
#3 | Japan | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Gangjee Aleem | 9 |
#2 | Monlish Darlene | 3 |
#3 | Chakrabarty Suravi | 3 |
#4 | Aleem Gangjee | 3 |
#5 | Matherly Larry H | 3 |
#6 | Cavanaugh Jane E | 3 |
#7 | Basu Partha | 2 |
#8 | Fleming Fraser Fergusson | 2 |
#9 | Thomas John | 2 |
#10 | Peterson Antoinette | 2 |
Publication | Filing date | Title |
---|---|---|
US2017153180A1 | Compositions, methods and devices thereof for fluorescent analysis of gunshot residue | |
US2016229857A1 | Substituted pyrrolo[2,3-D]dipyrimidines for selectively targeting tumor cells with FR-alpha and FR-beta type receptors | |
AU2014318748A1 | Novel anthranilic amides and the use thereof | |
AU6724796A | Non-steroidal sulfatase inhibitor compounds and their method of use |